IL-9 / Janelia Fluor 635 / enokizumab

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP3-28023JF635 (View supplier product page)
Size 100 μl
Price $379.00
Antigen IL-9
Clone enokizumab
Host Human
Isotype IgG1
Conjugate Janelia Fluor 635
Target Species Human
Applications FC, ELISA, Functional
Description IL-9 Antibody (enokizumab) [Janelia Fluor® 635]
About IL-9 and Janelia Fluor 635
IL-9 The protein encoded by this gene is a cytokine that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin 9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness. [provided by RefSeq, Jul 2008]
Janelia Fluor 635 Janelia Fluor® 635 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 635 has an excitation peak at 635 nm and an emission peak at 652 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 635 Excitation and Emission Spectra